[Tetracycline sclerotherapy of hydroceles and spermatoceles].
40 patients were treated by aspiration and instillation of a 10% solution of tetracycline. 32 were cured after average 1.45 instillations. The dominating adverse effect was scrotal pain, reported by 55% of the patients. One patient experienced a transient vasovagal reaction due to the pain, and one patient was suspected of having a slight infection. No other adverse effect was registered, and 90% of the patients would prefer to have the same treatment rather than an operation if another treatment were found necessary. The treatment is given as an outpatient procedure at 1/10 of the cost of traditional operative treatment, and with comparable results.
Ovrebø
K K
KK
Kirurgisk avdeling, Sentralsjukehuset i Sogn og Fjordane, Førde.
Vaage
S
S
D000328:Adult; D000368:Aged; D006801:Humans; D008297:Male; D008875:Middle Aged; D010146:Pain / Q000209:etiology; D012008:Recurrence; D012597:Sclerosing Solutions / Q000008:administration & dosage* / Q000009:adverse effects; D012611:Scrotum / Q000187:drug effects; D013088:Spermatocele / Q000628:therapy*; D006848:Testicular Hydrocele / Q000628:therapy*; D013752:Tetracycline / Q000008:administration & dosage* / Q000009:adverse effects
D012597:Sclerosing Solutions; D013752:Tetracycline
Tetracyklinsklerosering av hydroceler og spermatoceler.